These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31155432)

  • 1. Producing the 'problem' of new psychoactive substances (NPS) in English prisons.
    Duke K
    Int J Drug Policy; 2020 Jun; 80():102479. PubMed ID: 31155432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Keeping a lid on it': Exploring 'problematisations' of prescribed medication in prisons in the UK.
    Duke K; Trebilcock J
    Int J Drug Policy; 2022 Feb; 100():103515. PubMed ID: 34798433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adding Spice to the Porridge: The development of a synthetic cannabinoid market in an English prison.
    Ralphs R; Williams L; Askew R; Norton A
    Int J Drug Policy; 2017 Feb; 40():57-69. PubMed ID: 27955961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "A spray bottle and a lollipop stick": An examination of policy prohibiting sterile injecting equipment in prison and effects on young men with injecting drug use histories.
    Walker S; Seear K; Higgs P; Stoové M; Wilson M
    Int J Drug Policy; 2020 Jun; 80():102532. PubMed ID: 31427211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Problematisation and centralised assessment in drug treatment sector reform.
    Berends L
    Int J Drug Policy; 2020 Jun; 80():102561. PubMed ID: 31611166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The "problem" of health: An analysis of health care provision in Canada's federal prisons.
    Scallan E; Lancaster K; Kouyoumdjian F
    Health (London); 2021 Jan; 25(1):3-20. PubMed ID: 31055943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985-2010.
    Lancaster K; Ritter A
    Int J Drug Policy; 2014 Jan; 25(1):81-7. PubMed ID: 23931957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responding to 'wicked problems': policy and governance on drug-related deaths in English and Welsh prisons, 2015-2021.
    Duke K; MacGregor S
    Int J Drug Policy; 2024 Apr; 126():104358. PubMed ID: 38401175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Psychoactive Substances and Violence within a UK Prison Setting.
    Mason R; Smith M; Onwuegbusi T; Roberts A
    Subst Use Misuse; 2022; 57(14):2146-2150. PubMed ID: 36269768
    [No Abstract]   [Full Text] [Related]  

  • 10. [Guidelines for substitution treatments in prison populations].
    Michel L; Maguet O
    Encephale; 2005; 31(1 Pt 1):92-7. PubMed ID: 15971645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a framework for safe and appropriate prescribing of psychoactive medications in a UK prison.
    Bebbington E; Lawson J; Nafees S; Robinson C; Poole R
    Crim Behav Ment Health; 2021 Apr; 31(2):131-142. PubMed ID: 33306258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New psychoactive substances, safety and mental health in prison officers.
    Kinman G; Clements AJ
    Occup Med (Lond); 2021 Nov; 71(8):346-350. PubMed ID: 34415337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of drug-impregnated paper samples seized in English prisons between 2018 and 2020.
    Akca AA; Couchman L; Frinculescu A; Johnston A
    Forensic Sci Int; 2024 Apr; 357():111991. PubMed ID: 38513529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Producing the vulnerable subject in English drug policy.
    Brown K; Wincup E
    Int J Drug Policy; 2020 Jun; 80():102525. PubMed ID: 31395470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Potential issues of morbidity, toxicity and dependence': Problematizing the up-scheduling of over-the-counter codeine in Australia.
    Weier M; Farrugia A
    Int J Drug Policy; 2020 Jun; 80():102538. PubMed ID: 31362859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances.
    Chiappini S; Vaccaro G; Mosca A; Miuli A; Stigliano G; Stefanelli G; Giovannetti G; Carullo R; d'Andrea G; Di Carlo F; Cavallotto C; Pettorruso M; Di Petta G; Corkery JM; Guirguis A; Stair JL; Martinotti G; Fazel S; Schifano F
    Neurosci Biobehav Rev; 2024 Jul; 162():105691. PubMed ID: 38733894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The print media's construction of the 'drug problem' in Victorian newspapers: The case of North Richmond Community Health's medically supervised injecting room.
    Whiteside B; Dunn M
    Drug Alcohol Rev; 2022 May; 41(4):818-829. PubMed ID: 34674323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the development of a regulated market approach to new psychoactive substances (NPS) in New Zealand using Punctuated Equilibrium Theory.
    Rychert M; Wilkins C
    Addiction; 2018 Nov; 113(11):2132-2139. PubMed ID: 29744945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring motivations to stop injecting in English prisons: qualitative research with former male prisoners.
    Tompkins CN
    Int J Prison Health; 2013; 9(2):68-81. PubMed ID: 25758439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence and predictors of psychoactive substance use among men in prisons].
    Caravaca-Sánchez F; Falcón Romero M; Luna A
    Gac Sanit; 2015; 29(5):358-63. PubMed ID: 26228003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.